Surgical-pathologic risk factors of pelvic lymph node metastasis in stage Ib1-IIb cervical cancer

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 7, 2012, Pages 802-809

  Li, Donglin ^a,b   Cai, Jing ^a   Kuang, Yan ^a   Cao, Jin ^a   Wang, Zehua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; Infiltration; Lymph node metastasis; Retrospective study; Risk factor

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER INFILTRATION; CANCER RISK; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; META ANALYSIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RETROSPECTIVE STUDY; SURGICAL RISK; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERUS CARCINOMA;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PELVIS; RISK FACTORS; STATISTICS, NONPARAMETRIC; UTERINE CERVICAL NEOPLASMS;

EID: 84862847256     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01415.x     Document Type: Article

References (30)

1. Arbyn M, Antoine J, Valerianova Z, Magi M, Stengrevics A, Smailyte G, et al. Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania. Tumori. 2010;96:517-23.
2. Delgado G BB ZR, Sevin B, CreasmanWT, Major F. Prospective surgical-pathologic study of disease-free interval in patients with stage Ib squamous carcinoma of the cervix. Gynecol Oncol. 1990;38:352-7.
3. Trattner M, Graf AH, Lax S, Forstner R, Dandachi N, Haas J, et al. Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol. 2001;82:11-6.
4. Suprasert P, Srisomboon J, Kasamatsu T. Radical hysterectomy for stage IIB cervical cancer: a review. Int J Gynecol Cancer. 2005;15:995-1001.
5. Monk BJ CD,Walker JL, Burger RA, Ramsinghani NS, Manetta A, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol Oncol. 1994;54:4-9.
6. Sakuragi N, Satoh C, Takeda N, Hareyama H, Takeda M, Yamamoto R, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85:1547-54.
7. Aoki Y, Sasaki M,Watanabe M, Sato T, Tsuneki I, Aida H, et al. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol. 2000;77:305-9.
8. Yeh SA,Wan Leung S,Wang CJ, Chen HC. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors. Gynecol Oncol. 1999;72:10-5.
9. Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S, Sasajima Y, et al. Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix. Br J Cancer. 2009;100:1400-5.
10. Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand. 2002;81:1144-51.
11. Hosaka M,Watari H, Mitamura T, Konno Y, Odagiri T, Kato T, et al. Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy. Int J Clin Oncol. 2011;16:33-8.
12. Marana HR, de Andrade JM, Dos Reis FJ, Tiezzi DG, Zola FE, ClagnanWS, et al. Impact of surgical staging in locally advanced cervical cancer and subsequent chemotherapy. J Surg Oncol. 2009;100:505-10.
13. Benedetti-Panici P, Maneschi F, Scambia G, Greggi S, Cutillo G, D'Andrea G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol. 1996;62:19-24.
14. Moore KN, Gold MA, McMeekin DS,Walker JL, Rutledge T, Zorn KK. Extraperitoneal para-aortic lymph node evaluation for cervical cancer via pfannenstiel incision: technique and peri-operative outcomes. Gynecol Oncol. 2008;108:466-71.
15. Boughanim M, Leboulleux S, Rey A, Pham CT, Zafrani Y, Duvillard P, et al. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol. 2008;26:2558-61.
16. Monteil J, Maubon A, Leobon S, Roux S, Marin B, Renaudie J, et al. Lymph node assessment with 18F-FDG-PET andMRI in uterine cervical cancer. Anticancer Res. 2011;31:3865-71.
17. Hertel H. Cervical cancer and the role of lymph node staging cons sentinel concept. Int J Gynecol Cancer. 2010;20(11 Suppl 2):S37-8.
18. Crane LM, Themelis G, Pleijhuis RG, Harlaar NJ, Sarantopoulos A, Arts HJ, et al. Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol. 2011;13:1043-9.
19. Vidaurreta J, Bermudez A, di Paola G, Sardi J. Laparoscopic staging in locally advanced cervical carcinoma: A new possible philosophy? Gynecol Oncol. 1999;75:366-71.
20. Zander J, Baltzer J, Lohe KJ, Ober KG, Kaufmann C. Carcinoma of the cervix: an attempt to individualize treatment. Results of a 20-year cooperative study. Am J Obstet Gynecol. 1981;139:752-9.
21. Zanvettor PH, Filho DF, Neves AR, Amorim MJ, Medeiros SM, Laranjeiras LC, et al. Laparoscopic surgical staging of locally advanced cervix cancer (IB2 to IVA): initial experience. Gynecol Oncol. 2011;120:358-61.
22. Bader AAWR, Moinfar F, Petru E, Pristauz G, Scholz HS, et al. Is intraoperative frozen section analysis of pelvic lymph nodes accurate after neoadjuvant chemotherapy in patients with cervical cancer? Gynecol Oncol. 2006;103:106-12.
23. Scholz HS, Lax SF, Benedicic C, Tamussino K,Winter R. Accuracy of frozen section examination of pelvic lymph nodes in patients with FIGO stage IB1 to IIB cervical cancer. Gynecol Oncol. 2003;90:605-9.
24. Fanfani F, Ludovisi M, Zannoni GF, Distefano M, Fagotti A, Ceccaroni M, et al. Frozen section examination of pelvic lymph nodes in endometrial and cervical cancer: accuracy in patients submitted to neoadjuvant treatments. Gynecol Oncol. 2004;94:779-84.
25. Ferrandina G, Fanfani F, Ludovisi M, Fagotti A, Carbone A, Zannoni G, et al. Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? Gynecol Oncol. 2008;108:220-5.
26. Michel G, Morice P, Castaigne D, Leblanc M, Rey A, Duvillard P. Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications. Obstet Gynecol. 1998;91:360-3.
27. Zighelboim I, Ramirez PT, Gao F, Slomovitz BM, Sun C, Frumovitz M, et al. Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol. 2006;15:79-83.
28. Lee JY, Kim YH, Kim MJ, Kim K, Chung HH, Park NH, et al. Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy. Arch Gynecol Obstet. 2011;284:477-82.
29. Yun-Hyun Cho, Dae-Yeon Kim, Jong-Hyeok Kim, Yong-Man Kim, Young-Tak Kim, Joo-Hyun Nam. Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer. J Gynecol Oncol. 2009;20:22-27.
30. Hee Seung Kim, Ju Yeong Kim, Noh Hyun Park, Kidong Kim, Hyun Hoon Chung, Yong Beom Kim, et al. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer. Gynecol Oncol. 2010;119:217-24.